Rationalized Discovery of Robust antiviral targets Using Genome-scale model Systems

This project focuses on the development of dormant nanoparticles that activate in response to specific biochemical signals, such as those associated with the reactivation of HSV-1 or the presence of disease markers in cancer. These nanoparticles deliver targeted therapies to neutralize viruses or target diseased cells before symptoms appear.

Code and report of ASAP Discovery x OpenADMET challenge (ADMET and Potency).